10 million SEK to national study of COVID-19

The Swedish Research Council is providing 10 million SEK to fund the ImmCoVA clinical study. The study is expected to run for three years, and focuses on immune blockers to counteract excess reaction of the immune system to the infection caused by COVID-19.

Foto: Chris McLay, Unsplash

In June, we reported that the Swedish Research Council was to fund Sweden’s participation in the Solidarity trial, a major clinical WHO study, where a number of antiviral medicines are tested on patients being treated for COVID-19. However, due to the high level of mortality seen in patients receiving some of these medicines, the Swedish network for the WHO study decided that Sweden would not participate in the study.

Instead, the Swedish Research Council is now providing the same network of infection clinics in Sweden with funding of 10 million SEK to conduct another national study into COVID-19. The study is called ImmCoVA, and is expected to run for three years, starting in October. The study focuses on immune blockers to counteract excess reaction of the immune system to infection, known as ‘cytokine storm’. The study will investigate whether treatment with two specific immunosuppressing substances can result in improvement, and at best in patients recovering more quickly than with standard treatments.

The Karolinska University Hospital is leading the study, and patients will be recruited from five university hospitals.




  1. Inauguration of the new centre of excellence Chemical Mechanisms of Life

    On 12 of April, there will be an inauguration of one of the new centres of excellence with funding from the Swedish Research Council: Chemical Mechanisms of Life – an interdisciplinary centre for research into the chemistry of life. Mattias Marklund,...

  2. The Swedish Research Council’s centres of excellence

    The Swedish Research Council is funding 15 centres of excellence as from 2024. The centres, which are being built up, shall carry out ground-breaking research and educational activities around a central theme.

  3. Just over 75 per cent of clinical studies registered after one year

    As from 2022, all clinical studies funded by the Swedish Research Council shall be registered in a public database. A recent follow-up shows that the majority of the clinical studies awarded funding in 2022 have been registered.